Castle Creek Biosciences

Exton, PA · Founded 2015 · Privately Held (backing)

Developer of a fibroblast based therepy designed to treat rare and serious genetic diseases. Castle Creek Biosciences is based in Exton, PA and was founded in 2015. It has raised $419 million across 4 recorded rounds; the latest was a $75 million later-stage round in Feb 2025.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$419.4M
Last round
Later Stage VC
Feb 2025

Who backs Castle Creek Biosciences?

5 investors
InvestorType
Fidelity Management & Research CompanyAsset manager
Valor Equity PartnersGrowth equity
Fidelity—
Paragon Biosciences—
U.S. Food and Drug Administration—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Castle Creek Biosciences investors

5 investors are on record for Castle Creek Biosciences, including Fidelity Management & Research Company, Valor Equity Partners, Fidelity and Paragon Biosciences. The later-stage round in Feb 2025 drew 30 investors.

Free account
More of Castle Creek Biosciences with a free account
  • ·Watch Castle Creek Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Castle Creek Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View